Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
XNK Therapeutics Appoints Hugo Petit as Chief Financial Officer
XNK Therapeutics today announced the appointment of Hugo Petit as Chief Financial Officer (CFO) and […]
Trinity Biotech Announces the $30 Million Sale of its Life Sciences Supply Business to Biosynth
Trinity Biotech, a leading developer and manufacturer of diagnostic solutions for the point-of-care and clinical […]
ValGenesis and Enterey Partner to Deliver a Better Consulting Experience for Life Sciences Companies Going Digital
ValGenesis, the market leader in enterprise Validation Lifecycle Management Systems (VLMS), and Enterey, a specialist […]
ProPharma Acquires UK Based Digital Lab Consulting
ProPharma Group (ProPharma) the leading global provider of regulatory, clinical, and quality services for the […]
Cryoport Announces New Strategic Partnership with Syneos Health to Advance Cell & Gene Therapies
Cryoport, a leading global provider of innovative temperature-controlled supply chain solutions to the life sciences […]
Hexaware Technologies Expands its Global Life Sciences and Healthcare IT Consulting and Technology Practice
Hexaware Technologies, one of the world’s leading global IT consulting, technology and digital solutions provider, […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more